Your browser doesn't support javascript.
loading
Venetoclax plus low-dose cytarabine in patients with newly diagnosed acute myeloid leukemia ineligible for intensive chemotherapy: an expanded access study in Japan.
Asada, Noboru; Ando, Jun; Takada, Satoru; Yoshida, Chikashi; Usuki, Kensuke; Shinagawa, Atsushi; Ishizawa, Kenichi; Miyamoto, Toshihiro; Iida, Hiroatsu; Dobashi, Nobuaki; Okubo, Sumiko; Honda, Hideyuki; Soshin, Tomomi; Nishimura, Yasuko; Tsutsui, Atsuko; Mukai, Harumi; Yamamoto, Kazuhito.
Afiliación
  • Asada N; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
  • Ando J; Department of Hematology, School of Medicine, Juntendo University, Tokyo, Japan.
  • Takada S; Leukemia Research Center, Gunma Saiseikai Maebashi Hospital, Maebashi, Japan.
  • Yoshida C; Department of Hematology, National Hospital Organization Mito Medical Center, Ibaraki-machi, Japan.
  • Usuki K; Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan.
  • Shinagawa A; Department of Internal Medicine, Hitachi General Hospital, Hitachi, Japan.
  • Ishizawa K; Department of Internal Medicine III, Yamagata University Faculty of Medicine, Yamagata, Japan.
  • Miyamoto T; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
  • Iida H; Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Dobashi N; Division of Clinical Oncology/Hematology, The Jikei University Daisan Hospital, Tokyo, Japan.
  • Okubo S; Department of Hematology and Cell Therapy, AbbVie GK, Osaka, Japan.
  • Honda H; Department of Hematology and Cell Therapy, AbbVie GK, Tokyo, Japan.
  • Soshin T; Department of Hematology and Cell Therapy, AbbVie GK, Tokyo, Japan.
  • Nishimura Y; Department of Hematology and Cell Therapy, AbbVie GK, Tokyo, Japan.
  • Tsutsui A; Department of Hematology and Cell Therapy, AbbVie GK, Tokyo, Japan.
  • Mukai H; Department of Hematology and Cell Therapy, Abbvie Inc., Singapore.
  • Yamamoto K; Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan.
Jpn J Clin Oncol ; 53(7): 595-603, 2023 Jun 29.
Article en En | MEDLINE | ID: mdl-37017320
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Síndrome de Lisis Tumoral Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies Límite: Aged / Aged80 / Humans / Middle aged País/Región como asunto: Asia Idioma: En Revista: Jpn J Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Síndrome de Lisis Tumoral Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies Límite: Aged / Aged80 / Humans / Middle aged País/Región como asunto: Asia Idioma: En Revista: Jpn J Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Japón